Entering text into the input field will update the search result below

Abbott Laboratories: The Dividend Growth King Of Healthcare

Apr. 07, 2021 6:55 AM ETAbbott Laboratories (ABT) Stock9 Comments
Wealth Insights profile picture
Wealth Insights


  • Abbott Labs is a healthcare conglomerate that has managed to grow despite restructuring its business over the past decade.
  • The company's strong fundamentals and top-line growth have resulted in strong cash flow and dividend growth.
  • The stock is reasonably valued, given an expected surge in EPS this year. Investors can do well by buying and holding this top notch company.

Illinois Drugmaker Under Investigation By State Attorney General
Photo by Tim Boyle/Getty Images News via Getty Images

One of the best indicators of a quality organization is one that proactively drives innovation, pushing the envelope rather than resting on existing success. When you have a business that continually adds value

This article was written by

Wealth Insights profile picture
Using fundamental analysis and common sense, I provide straightforward insights on stocks and markets. https://www.threads.net/@wealth__insight- Bachelor's degree in Business Administration with a concentration in Financial Analysis. Been investing and following the markets for more than a decade.- Wealth Insights is an investor and investment author. His content is not geared to anyone's investment goals, time horizons, or risk tolerance. Content is for illustrative purposes only and is not intended to displace advice from a fee-based financial adviser. It is not to be taken as investment advice or influence investor decision-making. The accuracy of data is not guaranteed.

Analyst’s Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Comments (9)

Buyandhold 2012 profile picture
I view ABT as a buy at $105 or lower and as a hold above $105.

The average annual return of Abbott Labs with dividend reinvestment for the 50 year period from January 1969 to January 2019 was 14.53%, much better than the S&P 500.

I have been an Abbott Labs shareholder for 51 years and I would never sell it. If it fell below $105, I might buy more.

I'm in love with Abbott Labs.

Hit it, Kelly Marie.

"My head is in a spin
My feet don't touch the ground
Because you're near me
My head goes round and round
My knees are shakin', baby
My heart it beats like a drum
It feels like
It feels like I'm in love."
GDPPP profile picture
@Buyandhold 2012 You never sell anything anyways. So with ABT, you would never ever ever ever Sell it :)

ABT is one of my 10 stocks to buy and hold over the next couple decades for sure. Silly traders sold this around $60 during Covid sell-off. I missed that dip as the stock came so close to my cost basis. Lesson learnt in future - to double down or quadruple when panic hits wall street market timers..
@GDPPP A BIG problem in that situation is that your trades won't execute. If you can even get into your brokerage.
Well written article.
Income4ever aka Cyclenut profile picture
1.50% Yield .... pass
@Income4ever aka Cyclenut Humira accounts for over half of ABBV's revenue, yet the patent expires soon so humira will soon have to compete with cheaper biosimilars. This seems risky imo. Also their payout ratio has been increasing dramatically in the past few years...I think there's a reason the market is pricing ABBV for a high current yield.

Lastly, try out dividend growth investing ;) it's about the delayed gratification that come from dividends funding your retirement in the future :D
AbbVie's acquisition of Allergan added several new drugs in aesthetics and women's health.
@Income4ever aka Cyclenut
Long both for the long haul.
Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!

About ABT

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on ABT

Related Stocks

SymbolLast Price% Chg
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.